Box 3.
Key questions for moderate impact non-DDI regulatory submissions. DDI drug–drug interaction, PK pharmacokinetics, PPI proton pump inhibitor, P-gp P-glycoprotein, Cmax maximum concentration
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.